An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CADTH Canadian Drug Expert Committee Recommendation: Migalastat (Galafold — Amicus Therapeutics): Indication: Fabry Disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jan.
Top results in this bookTable of Contents
CADTH Canadian Drug Expert Committee Recommendation: Nitisinone (Nitisinone Tablets — Cycle Pharmaceuticals Ltd.): Indication: The treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
CADTH Canadian Drug Expert Committee Recommendation: Nitisinone (MDK-Nitisinone — MendeliKABs Inc.): Indication: The treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Apr.
CADTH Canadian Drug Expert Committee Recommendation: Nitisinone (Orfadin — Sobi Canada Inc.): Indication: The treatment of adult and pediatric patients with hereditary tyrosinemia type-1 in combination with a dietary restriction of tyrosine and phenylalanine [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Feb.
CADTH Canadian Drug Expert Committee Recommendation: Eliglustat (Cerdelga — Sanofi Genzyme): Indication: Type 1 Gaucher disease [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Jul.
CADTH Canadian Drug Expert Committee Final Recommendation Sapropterin — Resubmission: (Kuvan — BioMarin Pharmaceuticals Canada Inc.): Indication: To reduce blood phenylalanine levels in patients with hyperphenylalaninemia due to BH4-responsive phenylketonuria [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Oct 26.
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet].
Bethesda (MD): National Institutes of Health (US); 2021 Apr 21-2024 Feb 29.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on